Category Press Releases

Microbot Medical Announces First Michigan Health System to Adopt the LIBERTY® Endovascular Robotic System

LIBERTY® Endovascular Robotic System Debuts in Michigan Through Leading Health System Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that one of the largest…

Read MoreMicrobot Medical Announces First Michigan Health System to Adopt the LIBERTY® Endovascular Robotic System
NanoDetection

NanoDetection and Oligomerix Sign Global Licensing Deal for Neurodegenerative Disease Antibodies

NanoDetection Technology and Oligomerix Enter Exclusive Global Licensing Agreement to Advance Next-Generation Neurodegenerative Disease Diagnostics NanoDetection Technology, Incorporated (NDT) and Oligomerix, Inc. have announced a significant strategic partnership through the…

Read MoreNanoDetection and Oligomerix Sign Global Licensing Deal for Neurodegenerative Disease Antibodies
Microbot

Microbot Medical Secures First International Regulatory Approval for LIBERTY Endovascular Robotic System

Microbot Medical Expands Global Reach as Israel Grants Marketing Approval for LIBERTY Endovascular Robotic System Microbot Medica a commercial-stage medical device company focused on advancing robotic technologies for endovascular procedures,…

Read MoreMicrobot Medical Secures First International Regulatory Approval for LIBERTY Endovascular Robotic System